Delisting Determination,The Nasdaq Stock Market, LLC,
October 7, 2008, Bioject Medical Technologies Inc. The Nasdaq Stock
Market, Inc. (the Exchange) has determined to remove from
listing the common stock of Bioject Medical Technologies Inc.
(the Company), effective at the opening of the
trading session on October 17, 2008. Based on a review of the
information provided by the Company, Nasdaq Staff
determined that the Company no longer qualified for
listing on the Exchange pursuant to Marketplace Rule
4310(c)(04). The Company was notified of the
Staffs determinations on May 20, 2008.
The Company requested a review of the
Staffs determination before the Listing
Qualifications Hearings Panel. Upon review of the
information provided by the Company, the Panel
determined that the Company did not qualify for
inclusion on the Exchange based on its failure to
comply with the following Marketplace Rule:
4310(c)(04). The Company was notified of the Panels
decision on July 21, 2008 and trading in the
Companys securities was suspended on July 23, 2008. The Company
did not request a review of the Panels decision by the
Nasdaq Listing and Hearing Review Council.
The Listing Council did not call the matter for
review. The Panels Determination to delist the Company
became final on September 4, 2008.